IDENTIFIKATION VON BIOMARKERN

European patent · EP3011059 · In force

Register entry

Publication number
EP3011059
Application number
EP14814334
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jun 18, 2014
Published
Apr 27, 2016
Granted
Feb 6, 2019
Protection ends at the latest
Jun 17, 2034
Next annual fee due
Jun 30, 2027
IPC classes
C12Q 1/6883 (2018.01)
G01N 33/53 (2006.01)
Priority
AU 2013902243 20.06.2013
PCT application
PCT/AU2014/050075 18.06.2014
PCT publication
WO2014/201516 24.12.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 14, 2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 14.08.2026

  2. Jul 1, 2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. Jul 1, 2024

    Change

    Published in Swissreg on 01.07.2024

  4. Jul 1, 2023

    Change

    Published in Swissreg on 01.07.2023

  5. Jul 1, 2022

    Change

    Published in Swissreg on 01.07.2022

  6. Feb 6, 2019

    Granted

    Published in Swissreg on 06.02.2019

Parties

Holder

ImmuneXpress Pty Ltd

Immunexpress Pty Ltd

6 Leonard Street, Boonah, Queensland 4310, AU

Inventor

MCHUGH, Leo Charles

Seattle, Washington 98122, US

BRANDON, Richard Bruce

Boonah, Queensland 4310, AU

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.